| 要約: | Snakes responsible for bites are rarely identified, resulting in a loss of information about snakebites from venomous species whose venom effects are poorly understood. A prospective clinical study including patients bitten by a snake was conducted in Cameroon between 2019 and 2021 to evaluate the efficacy and tolerability of a marketed polyvalent antivenom. Clinical presentation during the first 3 days of hospitalization was recorded following a standardized protocol. This ancillary study aimed to assess the frequency of bites by the different species encountered in Cameroon and to describe the symptoms of bites by formally identified species. Of the 447 patients included in the study, 159 (35.6%) brought the snake that caused the bite that was identified by a specialist. Out of these, 8 specimens could not be identified due to poor condition, 19 were non-venomous species, and 95 belonged to <i>Echis romani</i>—formerly <i>E. ocellatus</i>—species. The remaining 37 specimens included 2 <i>Atheris squamigera</i>, 12 <i>Atractaspis</i> spp., 2 <i>Bitis arietans</i>, 11 <i>Causus maculatus</i>, 1 <i>Dendroaspis jamesoni</i>, 1 <i>Naja haje</i>, 1 <i>N. katiensis</i>, 5 <i>N. melanoleuca</i> complex, and 2 <i>N. nigricollis</i>. Symptoms, severity of envenomation, and post-treatment course are described. Symptoms and severity of bites are consistent with cases described in the literature, but some specific features are highlighted.
|
|---|
